Researchers developed and validated an AI model that simultaneously detects multiple genetic markers in colorectal cancer tissue slides.
Key Details
- 1Study led by EKFZ for Digital Health at TU Dresden analyzed nearly 2,000 digitized pathology slides across seven independent cohorts in Europe and the US.
- 2The AI 'multi-target transformer' model predicts a wide range of genetic alterations, including microsatellite instability and BRAF/RNF43 mutations, from routine histological sections.
- 3Model performance matched or exceeded single-target models for key biomarkers and revealed the ability to identify shared morphological patterns tied to multiple mutations.
- 4Findings published in The Lancet Digital Health, with plans to extend methods to other cancers.
- 5Collaboration involved multiple academic centers, highlighting interdisciplinary and international partnership.
Why It Matters
This work represents a substantial advance for digital pathology and AI-driven precision diagnostics, potentially enabling faster, more comprehensive, and scalable assessment of genetic biomarkers directly from standard tissue images. Faster and lower-cost pre-screening for key mutations could streamline patient selection for molecular testing and personalize colorectal cancer care.
Source
EurekAlert
Related News
•EurekAlert
Deep Learning AI Outperforms Clinic Prognostics for Colorectal Cancer Recurrence
A new deep learning model using histopathology images identifies recurrence risk in stage II colorectal cancer more effectively than standard clinical predictors.
•EurekAlert
AI Reveals Key Health System Levers for Cancer Outcomes Globally
AI-based analysis identifies the most impactful policy and resource factors for improving cancer survival across 185 countries.
•EurekAlert
Dual-Branch Graph Attention Network Predicts ECT Success in Teen Depression
Researchers developed a dual-branch graph attention network that uses structural and functional MRI data to accurately predict individual responses to electroconvulsive therapy in adolescents with major depressive disorder.